Skip to main content

Blood Transfusions in Obstetrics (Green-top Guideline No. 47)

Published: 29/05/2015

This is the second edition of this guideline, which was previously published under the same title in 2007.

Obstetric conditions associated with the need for blood transfusion may lead to morbidity and mortality if not managed correctly. The increasingly important issues in blood transfusion are adverse events associated with transfusion, including potential infection and potential transmission of prions, rising costs and the possible future problems of availability.

The aim of this guideline is to update the previous guidance about the appropriate use of blood products that neither compromises the affected woman nor exposes her to unnecessary risk. Strategies to maximise the haemoglobin (Hb) level at delivery as well as to minimise blood loss are also discussed.

A statement summarising any conflicts of interest for this guideline is available here (PDF, 291.3 kb).